Status:
COMPLETED
Genetic Predisposition-Chronic Nephrotoxicity From CI-Liver Transplant Recipients-Potential Correlation-Urinary Biomarkers
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Northwestern Memorial Hospital
Conditions:
Complication of Transplanted Liver
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the relationship between genomic variants of components of the renin-angiotensin system and the development of kidney problems due to Calcineurin-inhibitors p...
Detailed Description
Study Design: This study will be a cross-sectional investigation of liver transplant recipients who received a liver transplant and have at least 6 months of follow-up. This study will be conducted a...
Eligibility Criteria
Inclusion
- Informed consent
- Males and females \> 18 years old
- Liver transplant recipients who have received a liver transplant at least 6 months ago
- Liver transplant recipients receiving a maintenance immunosuppression.
Exclusion
- Legal incapacity and/or other circumstances rendering the patient unable to understand the nature, scope and possible consequences of the study
- Pre-existing known kidney disease before liver transplantation
- Multi-organ transplant
Key Trial Info
Start Date :
July 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT00857844
Start Date
July 1 2007
End Date
May 1 2012
Last Update
May 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611